208 related articles for article (PubMed ID: 38244540)
41. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
[TBL] [Abstract][Full Text] [Related]
42. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
[TBL] [Abstract][Full Text] [Related]
43. [Establishment and characterization of A549 tumor monoclonal cell line with UCHL1 gene deletion].
Zhang Y; Shi Y; Song D; Zhang X; Yu L; He YP; Sun ZG
Sheng Li Xue Bao; 2018 Apr; 70(2):184-192. PubMed ID: 29691583
[TBL] [Abstract][Full Text] [Related]
44. Ubiquitin C-Terminal Hydrolase L1 regulates myoblast proliferation and differentiation.
Gao H; Hartnett S; Li Y
Biochem Biophys Res Commun; 2017 Oct; 492(1):96-102. PubMed ID: 28803986
[TBL] [Abstract][Full Text] [Related]
45. Ubiquitin C-terminal hydrolase L1 interacts with choline transporter in cholinergic cells.
Hartnett S; Zhang F; Abitz A; Li Y
Neurosci Lett; 2014 Apr; 564():115-9. PubMed ID: 24525247
[TBL] [Abstract][Full Text] [Related]
46. UCHL1 regulates inflammation via MAPK and NF-κB pathways in LPS-activated macrophages.
Zhang Z; Liu N; Chen X; Zhang F; Kong T; Tang X; Yang Q; Chen W; Xiong X; Chen X
Cell Biol Int; 2021 Oct; 45(10):2107-2117. PubMed ID: 34288216
[TBL] [Abstract][Full Text] [Related]
47. Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
Krabill AD; Chen H; Hussain S; Hewitt CS; Imhoff RD; Muli CS; Das C; Galardy PJ; Wendt MK; Flaherty DP
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668938
[TBL] [Abstract][Full Text] [Related]
48. UCHL1 promotes proliferation and metastasis in head and neck squamous cell carcinoma and could be a potential therapeutic target.
Zhang D; Fu Y; Tian G; Li J; Shang D; Zhou S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):684-697. PubMed ID: 35165060
[TBL] [Abstract][Full Text] [Related]
49. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways.
Gu YY; Yang M; Zhao M; Luo Q; Yang L; Peng H; Wang J; Huang SK; Zheng ZX; Yuan XH; Liu P; Huang CZ
Tumour Biol; 2015 Nov; 36(11):8379-87. PubMed ID: 26018507
[TBL] [Abstract][Full Text] [Related]
50. UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein.
Day IN; Thompson RJ
Prog Neurobiol; 2010 Mar; 90(3):327-62. PubMed ID: 19879917
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
Wulfänger J; Biehl K; Tetzner A; Wild P; Ikenberg K; Meyer S; Seliger B
Int J Cancer; 2013 Dec; 133(11):2522-32. PubMed ID: 23686552
[TBL] [Abstract][Full Text] [Related]
52. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo.
Zhang M; Cai F; Zhang S; Zhang S; Song W
Sci Rep; 2014 Dec; 4():7298. PubMed ID: 25466238
[TBL] [Abstract][Full Text] [Related]
54. Hyperfiltration in ubiquitin C-terminal hydrolase L1-deleted mice.
Boisvert NC; Holterman CE; Thibodeau JF; Nasrallah R; Kamto E; Comin CH; Costa LDF; Carter A; Hébert RL; Gutsol A; Cron GO; Lacoste B; Gray DA; Kennedy CR
Clin Sci (Lond); 2018 Jul; 132(13):1453-1470. PubMed ID: 29739827
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.
Yang G; Fan G; Zhang T; Ma K; Huang J; Liu M; Teng X; Xu K; Fan P; Cheng D
Med Sci Monit; 2018 Apr; 24():2072-2082. PubMed ID: 29627846
[TBL] [Abstract][Full Text] [Related]
56. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target.
Powis RA; Mutsaers CA; Wishart TM; Hunter G; Wirth B; Gillingwater TH
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):873-87. PubMed ID: 25041530
[TBL] [Abstract][Full Text] [Related]
57. UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
Br J Cancer; ; . PubMed ID: 34497382
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
